---

In This Issue:
The Venous Challenge

As interest in venous therapies increases, so must careful study and dedicated training.

Chief Medical Editor’s Page

The Venous Challenge By Barry T. Katzen, MD

COVER STORIES Levels of Evidence Required to Determine the Benefit of Treating CCSVI to Alleviate Symptoms of MS

An interventional perspective. Top 5 Viewed By Gary Siskin, MD

A neurology perspective. Top 5 Viewed By Patricia K. Coyle, MD, and Jack Burks, MD

Endovascular Options for Chronic DVT Top 5 Viewed What’s available and when to use these options. By Mark J. Garcia, MD, FSIR

Who Should Treat Vein Disease? Defining higher standards for vein specialists. By Steve Elias, MD, FACS, FACPh, and Jose I. Almeida, MD, FACS, RPVI, RVT

A Closer Look at Venous Disease Stratification Will continued reinvention result in a better wheel? By Michael A. Vasquez, MD, FACS, RVT, and Cary Munschauer, BA

Upcoming IVC Filter Data From the American Venous Registry The importance of data collection and how you can participate in much-needed research. By The American Venous Forum

One Question … How Have Your Protocols for IVC Filter Placement, Monitoring, and Retrieval Changed in the Past Several Years? With H. Bob Smouse, MD; David Trost, MD; John E. Rectenwald, MD, MS; Frank R. Arko, MD; John A. Kaufman, MD, MS; Graham Plant, MBBS, FRCR; Marvin D. Atkins, MD; Mahmood K. Razavi, MD; and Raman Uberoi, BMSCPath, MBBChir, MRCP, FRCR

Pharmacology

Update on Antiplatelet Therapy for Peripheral Arterial Disease Top 5 Viewed Current data and guidelines for choosing the best pharmacological option for each PAD patient. By Stephen L. Chastain, MD, and Marcus D. Stanbro, DO, FSVM

Platelet Inhibitors: Balancing Art and Science A case-based look at platelet inhibitors and peripheral arterial intervention. By Bruce H. Gray, DO, MSVM, FSCAI

Clopidogrel Considerations A look at the black box warning, implications of generic options, the need for peripheral trials, and the potential for genetic testing. By Karthikeshwar Kasirajan, MD

Techniques

Applicability of Heparin-Bonded Hybrid Vascular Grafts A case-based review in various vascular settings. By Brant W. Ullery, MD; Ben M. Jackson, MD; Joseph Bavaria, MD; and Edward Y. Woo, MD

FEATURED TECHNOLOGY

Sponsored by Bayer HealthCare Current Trends in Interventional DVT Management Top 5 Viewed A roundtable discussion of the challenges faced in treating deep vein thrombosis and the benefits of endovascular therapy. By Mark J. Garcia, MD, FSIR; Robert Lookstein, MD; Mehdi H. Shishehbor, DO, MPH; and Jeffrey Wang, MD

Departments

Innovations A preview of today’s new products

An Interview With Firas F. Mussa, MD, MS, FACS Dr. Mussa shares his insights on the future of TEVAR for uncomplicated type B aortic dissection, percutaneous EVAR, and treatment options for CLI.